Valuation (38%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.03 | 31.62 |
| PEG Ratio (TTM) | -0.96 | -1.19 |
| P/S Ratio (TTM) | 0.29 | 4.68 |
| P/B Ratio (TTM) | 0.44 | 6.14 |
| P/FCF Ratio (TTM) | 2.32 | 34.45 |
| Price to 5YR AVG Earnings Ratio | N/A | 47.14 |
| Price to 5YR AVG FCF Ratio | N/A | 53.02 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -9.70% | 8.86% |
| ROE (TTM) | -22.97% | 21.84% |
| Net Profit Margin (TTM) | -14.16% | 11.80% |
| ROIC 5YR AVG | N/A | 20.74% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -485.40% | 0.92% | N/A |
| Revenue | -3.20% | 22.44% | N/A |
| Net Income | -484.58% | 16.56% | N/A |
| Cash Flow | -47.61% | -50.93% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.68 | 1.72 |
| Quick Ratio (TTM) | 1.31 | 1.16 |
| D/E Ratio (TTM) | 0.45 | 0.63 |
| Interest Coverage (TTM) | -194.00 | 17.63 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 1.28 | 5.33 |
| LTL to 5YR AVG FCF | N/A | 5.98 |
| Shares Outstanding Growth 5YR AVG | N/A | 0.61% |